Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
Alveo Technologies
2 followers
Imbria Pharmaceuticals
2 followers
Queen Mary University
7 followers
Priovant
4 followers
Odyssey Therapeutics
4 followers
Auron Therapeutics
1 follower
Kriya Therapeutics
3 followers
Centessa Pharmaceuticals
3 followers
Strand Therapeutics
3 followers
Nexxen
15 followers
Arc Institute
4 followers
Bioretec
1 follower